Suppr超能文献

皮肤色素脱失在墨西哥恶性黑色素瘤患者中的预后意义。

Prognostic significance of cutaneous depigmentation in Mexican patients with malignant melanoma.

作者信息

Rodríguez-Cuevas S, López-Chavira A, Zepeda del Río G, Cuadra-García I, Fernández-Diez J

机构信息

Departamento de Tumores de Cabeza, Cuello y Piel, México, D.F.

出版信息

Arch Med Res. 1998 Summer;29(2):155-8.

PMID:9650331
Abstract

BACKGROUND

The clinical significance of cutaneous depigmentary phenomena in patients with malignant melanoma is not clear. There are two varieties: 1) vitiligo (VIT), and 2) leukoderma acquisitum centrifugum (LAC).

METHODS

In order to evaluate the outcome of our patients with malignant melanoma and skin depigmentation (VIT or LAC), the patients in this study with this association were retrospectively reviewed and compared with the total melanoma patients at the Oncology Hospital and the XXI Century National Medical Center of the Mexican Social Security Institute in Mexico City.

RESULTS

Nine cases were found from 1985-1995. There were eight women and one man, their mean age was 63 years. Six melanomas were located in the foot, one in the leg, one in the anus and one in the neck. All were Clark's levels III, IV or V, and their mean tumor thickness was 5.7 mm. Four out of nine patients had regional lymph node metastasis. Six melanomas were associated with VIT and three with LAC. Three patients developed the depigmentation after chemo- or chemoimmunotherapy. All nine patients are alive (100%) with a mean follow-up of 55 months (9-141), eight out of nine have no evidence of tumor.

CONCLUSIONS

From these data it may be concluded that the study patients with malignant melanoma and VIT or LAC have a higher-than-expected survival according to their prognostic factors. Therefore, the presence of the depigmentation phenomena must be looked for intentionally.

摘要

背景

恶性黑色素瘤患者皮肤色素脱失现象的临床意义尚不清楚。有两种类型:1)白癜风(VIT),2)离心性后天性白斑(LAC)。

方法

为了评估恶性黑色素瘤合并皮肤色素脱失(VIT或LAC)患者的预后,对本研究中患有这种关联的患者进行了回顾性分析,并与墨西哥城肿瘤医院和墨西哥社会保障研究所二十一世纪国家医疗中心的所有黑色素瘤患者进行了比较。

结果

1985年至1995年共发现9例。其中8名女性,1名男性,平均年龄63岁。6例黑色素瘤位于足部,1例位于腿部,1例位于肛门,1例位于颈部。所有病例均为Clark III、IV或V级,平均肿瘤厚度为5.7毫米。9名患者中有4名出现区域淋巴结转移。9例黑色素瘤中,6例与VIT相关,3例与LAC相关。3例患者在化疗或化疗免疫治疗后出现色素脱失。所有9名患者均存活(100%),平均随访55个月(9 - 141个月),9名患者中有8名无肿瘤证据。

结论

从这些数据可以得出结论,根据预后因素,本研究中患有恶性黑色素瘤且合并VIT或LAC的患者生存率高于预期。因此,必须有意寻找色素脱失现象的存在。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验